TOPICS
Upsell & Cross-Sell for Digital Health & Telehealth
DIRECT ANSWER
Upselling encourages an existing customer to upgrade to a higher-tier product or add more capacity. Cross-selling introduces complementary products that enhance what the customer already owns. Both strategies grow revenue from the existing customer base at significantly lower cost than acquiring new customers—making them central to any retention and expansion marketing program. For Digital Health & Telehealth companies, this matters because Clinical validation is the purchase gate that most digital health companies hit too late — health system and payer buyers require peer-reviewed evidence of clinical outcomes before committing enterprise contracts, meaning marketing must start building the evidence story at seed, not Series B.
What upsell & cross-sell means for Digital Health & Telehealth
Digital health marketing that converts enterprise buyers requires a sequenced evidence narrative: peer-reviewed pilot data → reference health system customer in the buyer's region → EHR integration certification → ROI model built on the buyer's own population data. Skipping any step in this sequence loses the deal to a competitor who has it. For consumer telehealth, SEO on high-intent symptom and condition queries (structured as health content, not promotional copy) is the highest-ROI acquisition channel because health system search volumes are enormous and organic ranks persist. HIPAA BAA availability must be stated on the first marketing touchpoint — enterprise buyers screen for it before opening a case study.
For Digital Health & Telehealth teams the relevant marketing pains are: Clinical validation is the purchase gate that most digital health companies hit too late — health system and payer buyers require peer-reviewed evidence of clinical outcomes before committing enterprise contracts, meaning marketing must start building the evidence story at seed, not Series B; EHR integration with Epic, Cerner, or athenahealth is a prerequisite for clinical workflow adoption — any platform without a certified Epic App Orchard listing or Cerner Code partnership faces immediate disqualification from most health system RFPs; Consumer-facing telehealth markets have commoditized on price — differentiation on clinical quality, specialty breadth, and outcome data is the only defensible positioning as Amazon Clinic, CVS Health, and Walmart Health compete on distribution and brand; Reimbursement and coverage decisions are made by payers outside the vendor's control — a product that delivers clinical value but lacks CPT code reimbursement or payer coverage faces a perpetual adoption ceiling; Health system procurement moves through lengthy value analysis committee (VAC) reviews that require simultaneous clinical champion, IT security, compliance, legal, and finance sign-off before a purchase order is issued; Provider burnout and EHR documentation burden mean clinicians are hostile to any new technology that adds workflow steps — marketing must lead with time savings and workflow reduction, not feature breadth. HIPAA Privacy and Security Rules (BAA required with every enterprise customer); 21st Century Cures Act interoperability requirements (FHIR API compliance); FDA Software as a Medical Device (SaMD) regulations for diagnostic or clinical decision support tools; FTC Health Breach Notification Rule for consumer health data; state telehealth practice standards and prescribing regulations (vary by state — especially controlled substances post-COVID waiver expiration); CMS reimbursement coding accuracy in marketing claims; CCPA and state privacy laws for consumer health data not covered by HIPAA
Upsell vs. Cross-Sell: Key Differences
An upsell moves the customer to a more expensive version of what they already buy: a software plan with more seats, a higher storage tier, a premium service level. The customer is solving the same problem—just with more capacity or capability. A cross-sell introduces a different but related product: a customer who bought a CRM is offered an email automation add-on; a customer who bought shoes is offered matching socks. Cross-selling expands the relationship into adjacent needs.
Both techniques are most effective when they feel like helpful recommendations rather than revenue grabs. The best upsell or cross-sell offer is one the customer realizes they needed once they see it.
Running upsell & cross-sell for Digital Health & Telehealth with Hadrian
Hadrian's agents apply upsell & cross-sell across Health system and payer conferences (HIMSS, HLTH, ViVE, JP Morgan Healthcare Conference), Healthcare trade publications (Modern Healthcare, Health Affairs, NEJM Catalyst, Fierce Healthcare), Epic App Orchard, Cerner Code, and health system innovation program partnerships, Self-insured employer benefits channels (NBGH, Business Group on Health, broker/consultant networks), Clinical society and specialty organization partnerships (AHA, AMA, specialty colleges) for clinical credibility for Digital Health & Telehealth companies — tuned to Chief Digital Health Officer or VP of Digital Innovation at a health system; VP of Clinical Transformation or CMO-adjacent innovation lead; VP Benefits at a self-insured employer (500+ employees) seeking population health management tools; Chief Medical Officer or VP Clinical at a payer's value-based care division; at consumer telehealth, a VP Growth or CMO focused on patient acquisition and retention and run under your approval, alongside every other marketing function.
FAQ
Upsell & Cross-Sell for Digital Health & Telehealth — common questions
How do you upsell without feeling pushy?
Ground the upsell in the customer's actual usage or goals. 'You've used 90% of your storage this month—here is how upgrading works' is helpful. 'Upgrade to our premium plan for more features' with no context is noise. Data-driven, personalized triggers make upsells feel like service rather than sales.
How does upsell & cross-sell differ for Digital Health & Telehealth companies?
The fundamentals are the same, but Digital Health & Telehealth marketing carries specific constraints — Clinical validation is the purchase gate that most digital health companies hit too late — health system and payer buyers require peer-reviewed evidence of clinical outcomes before committing enterprise contracts, meaning marketing must start building the evidence story at seed, not Series B and HIPAA Privacy and Security Rules (BAA required with every enterprise customer); 21st Century Cures Act interoperability requirements (FHIR API compliance); FDA Software as a Medical Device (SaMD) regulations for diagnostic or clinical decision support tools; FTC Health Breach Notification Rule for consumer health data; state telehealth practice standards and prescribing regulations (vary by state — especially controlled substances post-COVID waiver expiration); CMS reimbursement coding accuracy in marketing claims; CCPA and state privacy laws for consumer health data not covered by HIPAA. Hadrian adapts execution to that context automatically.
BUILT BY HADRIAN'S AGENTS
This page was written by Hadrian — the autonomous CMO.
Hadrian runs every channel of your marketing on your live data. See it work on your brand.